Literature DB >> 10451405

New developments in the treatment of cardiac failure.

S Westaby1, O Franklin, M Burch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10451405      PMCID： PMC1718050          DOI： 10.1136/adc.81.3.276

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  14 in total

1.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

2.  Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading.

Authors:  H R Levin; M C Oz; J M Chen; M Packer; E A Rose; D Burkhoff
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

3.  Diuretics, potassium and arrhythmias in hypertensive coronary disease.

Authors:  H Ikram; E A Espiner; M G Nicholls
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children.

Authors:  R Hetzer; M Loebe; E V Potapov; Y Weng; B Stiller; E Hennig; V Alexi-Meskishvili; P E Lange
Journal:  Ann Thorac Surg       Date:  1998-11       Impact factor: 4.330

5.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

6.  Improved left ventricular function after chronic left ventricular unloading.

Authors:  O H Frazier; C R Benedict; B Radovancevic; R J Bick; P Capek; W E Springer; M P Macris; R Delgado; L M Buja
Journal:  Ann Thorac Surg       Date:  1996-09       Impact factor: 4.330

7.  Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study.

Authors:  E J Eichhorn; C M Heesch; J H Barnett; L G Alvarez; S M Fass; P A Grayburn; B A Hatfield; L G Marcoux; C R Malloy
Journal:  J Am Coll Cardiol       Date:  1994-11-01       Impact factor: 24.094

8.  A preliminary study of growth hormone in the treatment of dilated cardiomyopathy.

Authors:  S Fazio; D Sabatini; B Capaldo; C Vigorito; A Giordano; R Guida; F Pardo; B Biondi; L Saccà
Journal:  N Engl J Med       Date:  1996-03-28       Impact factor: 91.245

Review 9.  Cardiac adrenergic receptor effects of carvedilol.

Authors:  T Yoshikawa; J D Port; K Asano; P Chidiak; M Bouvier; D Dutcher; R L Roden; W Minobe; K D Tremmel; M R Bristow
Journal:  Eur Heart J       Date:  1996-04       Impact factor: 29.983

10.  Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.

Authors:  A M Feldman; M R Bristow; W W Parmley; P E Carson; C J Pepine; E M Gilbert; J E Strobeck; G H Hendrix; E R Powers; R P Bain
Journal:  N Engl J Med       Date:  1993-07-15       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.